Sunday, December 22

Tag: Ownership Changes

Williams Cos. to Buy Gulf Coast Natural Gas Storage Portfolio for $1.95 Billion
27Dec By adminNo Comments
World

Williams Cos. to Buy Gulf Coast Natural Gas Storage Portfolio for $1.95 Billion

Energy infrastructure company Williams Cos.has inked a deal to buy a portfolio of Gulf Coast natural-gas storage assets from an affiliate of commodities-trading company Hartree Partners for $1.95 billion.Williams on Wednesday said the acquisition includes six underground natural gas storage facilities in Louisiana and Mississippi with total capacity of 115 billion cubic feet, along with 230 miles of gas transmission pipeline and connections to Transco, the nation’s largest natural gas transmission pipeline.Copyright ©2023 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8
Read More
Bristol-Myers Squibb to Buy RayzeBio for $4.1 Billion
27Dec By adminNo Comments
World

Bristol-Myers Squibb to Buy RayzeBio for $4.1 Billion

Updated Dec. 26, 2023 12:33 pm ETDrug company Bristol-Myers Squibb struck a $4.1 billion deal to buy RayzeBio, in a bet on a re-emerging cancer drug technology. RayzeBio develops radiopharmaceutical drugs, which use targeted forms of radiation that are delivered directly to cancer cells. Earlier products using the technology struggled commercially, but further research led to another wave of promising therapies that can attack tumors while limiting damage to surrounding healthy cells. Copyright ©2023 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8
Read More
AstraZeneca to Buy Gracell Biotechnologies for $1.2 Billion
27Dec By adminNo Comments
World

AstraZeneca to Buy Gracell Biotechnologies for $1.2 Billion

AstraZeneca has agreed to buy Gracell Biotechnologies for a transaction value of $1.2 billion, as part of the former’s efforts to grow its cell therapies business.The upfront cash portion of the deal is $1.0 billion, a 62.0% premium to Gracell’s last closing price for its American depository shares of $6.19, AstraZeneca said in a statement Tuesday.Copyright ©2023 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8
Read More
Stocks Rise to Start Last Trading Week of Year
26Dec By adminNo Comments
Money

Stocks Rise to Start Last Trading Week of Year

Major indexes advanced to start the holiday-shortened trading week, with stocks looking to close out a positive year after a bruising 2022.The benchmark S&P 500 gained 0.4% Tuesday, leaving it within 0.5% of a record close. The tech-heavy Nasdaq Composite added 0.5%, and the blue-chip Dow Jones Industrial Average rose 0.4%, or about 159 points. The small-cap Russell 2000, which has outperformed the leading indexes in December, climbed 1.2%. Copyright ©2023 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8
Read More
Bristol-Myers Squibb to Buy RayzeBio for $4.1 Billion
26Dec By adminNo Comments
World

Bristol-Myers Squibb to Buy RayzeBio for $4.1 Billion

Updated Dec. 26, 2023 12:19 pm ETDrug company Bristol-Myers Squibb struck a $4.1 billion deal to buy RayzeBio, in a bet on a re-emerging cancer drug technology. RayzeBio develops radiopharmaceutical drugs, which use targeted forms of radiation that are delivered directly to cancer cells. Earlier products using the technology struggled commercially, but further research led to another wave of promising therapies that can attack tumors while limiting damage to surrounding healthy cells. Copyright ©2023 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8
Read More
AstraZeneca to Buy Gracell Biotechnologies for $1.2 Billion
26Dec By adminNo Comments
World

AstraZeneca to Buy Gracell Biotechnologies for $1.2 Billion

AstraZeneca has agreed to buy Gracell Biotechnologies for a transaction value of $1.2 billion, as part of the former’s efforts to grow its cell therapies business.The upfront cash portion of the deal is $1.0 billion, a 62.0% premium to Gracell’s last closing price for its American depository shares of $6.19, AstraZeneca said in a statement Tuesday.Copyright ©2023 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8
Read More
British Billionaire Strikes Deal to Acquire Minority Stake in Manchester United
24Dec By adminNo Comments
Money

British Billionaire Strikes Deal to Acquire Minority Stake in Manchester United

Updated Dec. 24, 2023 11:47 am ETBritish billionaire Jim Ratcliffe agreed to buy a minority stake in Manchester United in a deal that values the renowned soccer club at around $6.3 billion including debt and ends more than a yearlong sales process.Manchester United said Ratcliffe will buy 25% of Manchester United’s nonvoting shares, which are listed on the New York Stock Exchange and last traded at close to $20. He will pay $33 a share, the club said Sunday.Copyright ©2023 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8
Read More
British Billionaire Strikes Deal to Acquire Minority Stake in Manchester United
24Dec By adminNo Comments
World

British Billionaire Strikes Deal to Acquire Minority Stake in Manchester United

Updated Dec. 24, 2023 10:58 am ETBritish billionaire Jim Ratcliffe has struck an agreement to buy a minority stake in Manchester United in a deal that values the renowned soccer club at around $6.3 billion including debt and ends more than a yearlong sales process.The deal is expected to be announced later Sunday.Copyright ©2023 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8
Read More
Biden’s Foolish Snub of Nippon Steel
23Dec By adminNo Comments
Health

Biden’s Foolish Snub of Nippon Steel

Nippon Steel’s proposed $15 billion acquisition of U.S. Steel “appears to deserve serious scrutiny,” the White House said Thursday. The statement came after an outcry from protectionist lawmakers, including Sen. John Fetterman (D., Pa.), who have cited union and national-security concerns and vowed to block the sale. The anti-Japanese business rhetoric is reminiscent of the 1980s, when U.S.-Japan trade tensions threatened to undermine a critically important bilateral alliance during the Cold War.U.S. politicians’ unjustified criticisms of the deal could strain relations between the U.S. and Japan and weaken their collaboration on trade and economic security. The White House should work with allies on economic and military cooperation, not criticize them.Copyright ©2023 Dow Jones & Com...
Read More